CASPR - Center for Addiction Science, Policy, and Research

RECENT WORK

An Innovation Agenda for Addiction

Advancing development of breakthrough medicines to reduce addiction at scale.

JANUARY 2025

GLP-1s for Reducing Addiction

Everything you need to know.

NOVEMBER 2024

VA study on GLP-1s and opioid use in veterans

Our first collaboration with the Department of Veterans Affairs.

NOVEMBER 2024

GRACE for Opioid Use Disorder

A novel GLP-1 based harm reduction strategy.

JULY 2024

Podcast episode with Chris Hayes

Executive Director Nicholas Reville on addiction medicine, GLP-1s, and innovation policy.

JANUARY 2025

Addiction medicine doctors who use GLP-1s

“I’m now offering GLP-1s to nearly all my substance use disorder patients.”

SEPTEMBER 2024

Breakthrough medicines can solve addiction at scale. CASPR works to advance research, policy, and innovation to bring better options to patients worldwide.

Our free substack has our latest news: Recursive Adaptation